Butaxamine

Butaxamine
Clinical data
Other names	Butoxamine; BW 64-9; N-tert-Butyl-β-hydroxy-2,5-dimethoxyamphetamine; β-Hydroxy-N-tert-butyl-2,5-DMA; β-Hydroxy-N-tert-butyl-DOH
ATC code	None;
Identifiers
	IUPAC name (1S,2S)-1-(2,5-Dimethoxyphenyl)-2-(tert-butylamino)propan-1-ol;
CAS Number	1937-89-9 ;
PubChem CID	134495;
ChemSpider	118552 ;
UNII	0NM31M53PW;
ChEMBL	ChEMBL289093;
Chemical and physical data
Formula	C15H25NO3
Molar mass	267.369 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C[C@@H]([C@@H](C1=C(C=CC(=C1)OC)OC)O)NC(C)(C)C;
	InChI InChI=1S/C15H25NO3/c1-10(16-15(2,3)4)14(17)12-9-11(18-5)7-8-13(12)19-6/h7-10,14,16-17H,1-6H3/t10-,14-/m0/s1; Key:TWUSDDMONZULSC-HZMBPMFUSA-N;
	(verify)

Butaxamine (INNTooltip International Nonproprietary Name; also known as butoxamine or as BW 64-9) is a β₂-selective beta blocker.^[1]^[2] Its primary use is in experimental situations in which blockade of β₂ receptors is necessary to determine the activity of the drug (i.e. if the β₂ receptor is completely blocked, but the given effect is still present, the given effect is not a characteristic of the β₂ receptor). It has no clinical use. An alternative name is α-(1-[tert-butylamino]ethyl)-2,5-dimethoxybenzyl alcohol.

References

↑ "Definition: butoxamine from Online Medical Dictionary".
↑ Hillman KL, Doze VA, Porter JE (August 2005). "Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus". J. Pharmacol. Exp. Ther. 314 (2): 561–7. doi:10.1124/jpet.105.084947. PMID 15908513. S2CID 12446381. Archived from the original on 2019-12-14. Retrieved 2008-08-13.

External links

Butaxamine - Isomer Design

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by adding missing information.

[urlDefinition:_butoxamine_from_Online_Medical_Dictionary-1] "Definition: butoxamine from Online Medical Dictionary".

[pmid15908513-2] Hillman KL, Doze VA, Porter JE (August 2005). "Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus". J. Pharmacol. Exp. Ther. 314 (2): 561–7. doi:10.1124/jpet.105.084947. PMID 15908513. S2CID 12446381. Archived from the original on 2019-12-14. Retrieved 2008-08-13.

[1]

v t e Beta blockers (C07)
β, non-selective	Alprenolol Bopindolol Bupranolol Carteolol Cloranolol Mepindolol Nadolol Oxprenolol Penbutolol Pindolol/Iodopindolol Propranolol^# Sotalol Tertatolol Timolol^#
β₁-selective	Acebutolol Atenolol Betaxolol Bevantolol Bisoprolol^# Celiprolol Epanolol Esmolol Landiolol Metoprolol Nebivolol Practolol Talinolol
β₂-selective	Butaxamine
α₁- + β-selective	Arotinolol Carvedilol Labetalol
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

See also

References

External links